Insomnia disorder
Conditions
Interventions
Efficacy Observation Group of Ultrasound-Guided Stellate Ganglion Block :None
Sponsors
Guabgzhou First People‘s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Patients with chronic insomnia disorder who received ultrasound-guided stellate ganglion block (SGB) treatment at the Sleep Clinic of Guangzhou First People's Hospital between November 2023 and January 2025; 2.Met the DSM-5 diagnostic criteria for chronic insomnia disorder, with a baseline Pittsburgh Sleep Quality Index (PSQI) score >= 8; 3.Aged between 18 and 75 years; 4.Diagnosed with insomnia disorder, with pre-treatment heart rate variability (HRV) recordings indicating sympathetic hyperarousal; 5.Documented plans for medication reduction or discontinuation in medical records;
Exclusion criteria
Exclusion criteria: 1.Serious somatic comorbidities (e.g., active heart disease, severe hepatic or renal impairment); 2.Diagnosed with major psychiatric disorders (e.g., schizophrenia, bipolar disorder) within the past 6 months, or current risk of suicide; 3.Active autoimmune diseases, malignant tumors, or infections; 4.Allergy to local anesthetics, coagulation disorders, or currently receiving anticoagulant therapy; 5.Pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Pittsburgh Sleep Quality Index Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate Variability Parameters;Change in Patient Health Questionnaire-9 items Score;Change in Generalized Anxiety Disorder-7 Score; | — |
Countries
China
Contacts
Public ContactYanlu Ying
Guabgzhou First People‘s Hospital
Outcome results
None listed